Table 5 Multivariate analysis of factors associated with cancer-specific survival
From: Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
Variable | Category | Hazard ratio | 95% confidence interval | P value* |
|---|---|---|---|---|
Resection margin status | R1 vs. R0 | 1.86 | 0.69 - 5.04 | 0.22 |
Lymph node status | Positive vs. negative | 2.09 | 0.68 - 6.46 | 0.19 |
Tumor differentiation | Poor (G3) vs. moderate (G2) | 2.27 | 0.97 - 5.32 | 0.06 |
VEGF [pg/ml] | ≥ 32.1 vs. < 32.1 | 0.24 | 0.09 - 0.57 | 0.002 |
VEGFR-1 [pg/ml] | ≥ 78.5 vs. < 78.5 | 1.52 | 0.63 - 3.64 | 0.35 |
PlGF [pg/ml] | ≥ 11.4 vs. < 11.4 | 0.87 | 0.35 - 2.12 | 0.76 |
PDGF-AA [pg/ml] | ≥ 2336.3 vs. < 2336.3 | 4.58 | 1.43 - 14.69 | 0.01 |
PDGF-BB [pg/ml] | ≥ 7624.3 vs. < 7624.3 | 0.36 | 0.15 - 0.88 | 0.02 |
Ang-1 [pg/ml] | ≥ 29202.1 vs. < 29202.1 | 0.30 | 0.10 - 0.93 | 0.04 |
EGF [pg/ml] | ≥ 234.2 vs. < 234.2 | 1.92 | 0.81 - 4.54 | 0.14 |